Physician profile
Michelle A Thomas
NPI 1588674634
$1,526.14
in general payments reported to CMS, 2019-2025
20 companies · $30.04 in 2025
The $30.04 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.88 · 2021: $27.30 · 2022: $218 · 2023: $813 · 2024: $426 · 2025: $30.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,269.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $388.81 | 2022-2024 | Dupixent |
| Verrica Pharmaceuticals INC. | $263.36 | 2023-2024 | Ycanth |
| Glaxosmithkline, LLC. | $136.15 | 2022-2023 | Shingrix, Arexvy |
| Dexcom, INC. | $132.70 | 2023 | Dexcom G6 Transmitter |
| Abbott Laboratories | $132.41 | 2023 | Ensite Precision, Freestyle Libre 2 |
| Novo Nordisk INC | $61.18 | 2023-2024 | Ozempic, Wegovy |
| Exact Sciences Corporation | $52.42 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Lilly USA, LLC | $47.41 | 2023-2024 | Zepbound, Mounjaro, Jardiance |
| Abbvie INC. | $42.46 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.81 | 2022-2023 | |
| Shield Therapeutics INC | $39.58 | 2024 | |
| Amgen INC. | $37.03 | 2023-2024 | Repatha, Otezla |
| Dynavax Technologies Corporation | $29.46 | 2023 | Heplisav-B |
| Sanofi Pasteur INC. | $25.88 | 2022 | |
| Agile Therapeutics, INC. | $21.16 | 2024 | Twirla |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $20.91 | 2023 | Farxiga |
| Phadia US INC. | $16.16 | 2021 | |
| Pfizer INC. | $14.23 | 2024 | |
| Medtronic USA, INC. | $11.88 | 2019 | |
| Organon LLC | $11.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.